Headquarters: Login to unlock
Branches: Login to unlock
Sub-Industries: Login to unlock
Industries: Login to unlock
Geographical Focus: Login to unlock
Company Information
BioNTech is a next generation immunotherapy company pioneering novel therapies for cancer and other serious diseases. The company exploits a wide array of computational discovery and therapeutic drug platforms for the rapid development of novel biopharmaceuticals. Based on its deep expertise in mRNA vaccine development and in-house manufacturingcapabilities, BioNTech and its collaborators are developing multiple mRNA vaccine candidates for a range of infectious diseases alongside its diverse oncology pipeline.
Estimated Deployed Capital
$693.3M
Development Stage
N/A
Location
Rheinland-Pfalz, Germany
Branches
N/A
Investor Type
Corporate
Ticket Size
N/A
Geographical Focus
N/A
Industry Focus
N/A
Portfolio Insights
Geography Breakdown
Industry Breakdown
